Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
The study investigators
Research output: Contribution to journal › Article › peer-review
141Scopus
citations
Fingerprint
Dive into the research topics of 'Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial'. Together they form a unique fingerprint.